Figure 1.

LINC00857 expression in MIBC. Association of LINC00857 expression with response to (A) gemcitabine/cisplatin (Gem/Cis; responders, n = 4; nonresponders, n = 7) and platinum‐based chemotherapy (responders, n = 7; nonresponders n = 10). B, LINC00857 expression in normal urothelium (n = 16) and MIBC (n = 122). Expression data were analyzed using unpaired t test (*P < .05; line represent the median; the whiskers represent 10th and 90th percentile). Kaplan‐Meier analysis showing correlation between LINC00857 expression levels with (C) recurrence‐free and (D) overall survival in MIBC MiTranscriptome cohort. The high and low LINC00857 expression groups were determined based on the 75th and 25th percentiles. The survival curves were analyzed using the log‐rank test